[Guidelines for treatment of hepatitis C].
作者信息
Iino Shiro
机构信息
Internal Medicine, Seizankai Kiyokawa Hospital.
出版信息
Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):342-6.
PMID:15359818
Abstract
摘要
相似文献
1
[Guidelines for treatment of hepatitis C].
Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):342-6.
2
[Combination therapy of interferon plus ribavirin for chronic hepatitis C].
Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):467-73.
3
[Therapeutic strategies for hepatitis C].
Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):441-7.
4
Delaying HCV treatment in HIV-positive patients.
IAPAC Mon. 2005 May;11(5):147.
5
ADVANCE study begins enrollment.
AIDS Patient Care STDS. 2008 Apr;22(4):345. doi: 10.1089/apc.2008.9957.
6
Treatment duration for genotypes 2 and 3: still confusing after all these years.
J Clin Gastroenterol. 2010 Sep;44(8):527-8. doi: 10.1097/MCG.0b013e3181e0b1ce.
7
Shortened therapy for hepatitis C virus genotype 2 or 3--is less more?
N Engl J Med. 2007 Jul 12;357(2):176-8. doi: 10.1056/NEJMe078092.
8
A crossing in therapy for hepatitis C virus genotype 2 or 3: increasing ribavirin dose with shortened duration or reducing ribavirin dose with standard duration.
Hepatology. 2009 Apr;49(4):1395-6; author reply 1396. doi: 10.1002/hep.22863.
9
Response-guided therapy for acute hepatitis C: applying concepts from chronic treatment.
Liver Int. 2011 Jul;31(6):903-4. doi: 10.1111/j.1478-3231.2011.02510.x. Epub 2011 Mar 22.
10
Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection.
N Engl J Med. 2005 Sep 15;353(11):1182-3; author reply 1182-3.
Zotero 插件